Venterzyme Pharmaceutical Private Limited
About Venterzyme Pharmaceutical Private Limited
Data last updated:
Venterzyme Pharmaceutical Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 December 2022.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24290KA2022PTC168535.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Samta Sharma and Keshar Mal Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Site No 49 Kno 18/6 Doddanagamangala Begur Hobli, Bangalore, Karnataka, India – 560100.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressSite No 49 Kno 18/6 Doddanagamangala Begur Hobli, Bangalore, Karnataka, India – 560100
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Venterzyme Pharmaceutical Private Limited FY 2025 filings available
Financial Statement Summary of Venterzyme Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Venterzyme Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Venterzyme Pharmaceutical are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Venterzyme Pharmaceutical Private Limited
Venterzyme Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samta Sharma | Director | 01 Dec 2022 | 3 Years 10 Months | Current |
| Keshar Mal Yadav | Director | 01 Dec 2022 | 3 Years 10 Months | Current |
Charges & Borrowings of Venterzyme Pharmaceutical Private Limited
Venterzyme Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Venterzyme Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Venterzyme Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Venterzyme Pharmaceutical Private Limited
Venterzyme Pharmaceutical Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Keshar Mal Yadav was appointed as Director on 01 Dec 2022.
Credit Ratings, Litigation & Regulatory Alerts for Venterzyme Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Venterzyme Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Venterzyme Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Venterzyme Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Venterzyme Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venterzyme Pharmaceutical Private Limited
Venterzyme Pharmaceutical is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 December 2022 (4+ years old) and is registered under CIN U24290KA2022PTC168535.
Venterzyme Pharmaceutical has 2 current directors:
- Samta Sharma - Director
- Keshar Mal Yadav - Director
The CIN (Corporate Identification Number) of Venterzyme Pharmaceutical is U24290KA2022PTC168535. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Venterzyme Pharmaceutical was incorporated on 01 December 2022, making it 4+ years old. It is registered with the Registrar of Companies, Bangalore.
Keshar Mal Yadav was appointed as Director on 01 Dec 2022. Samta Sharma was appointed as Director on 01 Dec 2022.
The registered office of Venterzyme Pharmaceutical is at Site No 49 Kno 186 Doddanagamangala Begur Hobli, Bangalore, Karnataka, India – 560100.
Venterzyme Pharmaceutical has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Venterzyme Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
No. Venterzyme Pharmaceutical is not listed on any stock exchange. It is an unlisted company.
The compliance status of Venterzyme Pharmaceutical is compliant as of 15 August 2026. The company is actively filing with the Registrar of Companies.